{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:10:56Z","timestamp":1792815056381,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Proton pump inhibitors (PPIs) are widely prescribed, especially in older adults with multiple comorbidities. However, their long-term use may lead to under-recognized adverse effects, including hypomagnesemia and related electrolyte disturbances, with potential neuromuscular and cognitive consequences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>An 84-year-old man with several chronic conditions and prolonged PPI therapy presented with recurrent dysphagia, neuromuscular symptoms, and seizure-like episodes. Laboratory tests consistently showed hypokalemia and hypocalcemia, with intermittent hypomagnesemia, despite ongoing supplementation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>A comprehensive medication review led to the discontinuation of both pantoprazole and Levetiracetam. The Naranjo algorithm was used to assess causality, indicating a probable adverse drug reaction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome<\/jats:title><jats:p>Following drug withdrawal, the patient experienced marked clinical improvement, with normalization of electrolyte levels. He no longer required supplementation and maintained stability through dietary management and adjustment of his antihypertensive therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case highlights the dual iatrogenic role of PPIs and antiepileptics in causing persistent electrolyte imbalances. It emphasizes the need for regular medication reviews in elderly, polymedicated patients to prevent functional decline and promote recovery.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1646741","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:40:48Z","timestamp":1758087648000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Multiple electrolyte disturbance with severe neurological manifestations induced by chronic use of PPIs"],"prefix":"10.3389","volume":"12","author":[{"given":"Alexander","family":"Bertuccioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cardinali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Pierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano Bruno","family":"Zonzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Zerbinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Maria","family":"Palazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-pump inhibitors: understanding the complications and risks","volume":"14","author":"Malfertheiner","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5527\/wjn.v1.i6.151","article-title":"Proton pump inhibitor-induced hypomagnesemia: a new challenge","volume":"1","author":"Florentin","year":"2012","journal-title":"World J Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5414\/CNCS111284","article-title":"Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: case reports with a mini-review of the literature","volume":"12","author":"Souza","year":"2024","journal-title":"Clin Nephrol Case Stud"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00228-016-2024-2","article-title":"Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series","volume":"72","author":"Pasina","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.53555\/jptcp.v31i8.7281","article-title":"Chronic proton pump inhibitor use leading to refractory hypomagnesaemia in a patient with rheumatoid arthritis: a case report","volume":"31","author":"Rizwanullah","year":"2024","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/ki.2012.462","article-title":"Proton pump inhibitors and hypomagnesemia: a rare but serious complication","volume":"83","author":"Perazella","year":"2013","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3858\/emm.2012.44.11.077","article-title":"Apical acidity decreases inhibitory effect of omeprazole on Mg2+ absorption and claudin-7 and -12 expression in Caco-2 monolayers","volume":"44","author":"Thongon","year":"2012","journal-title":"Exp Mol Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e13846","DOI":"10.1111\/apha.13846","article-title":"Mechanisms of proton pump inhibitor-induced hypomagnesemia","volume":"235","author":"Gommers","year":"2022","journal-title":"Acta Physiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5603\/ep.98576","article-title":"Hypomagnesaemia leading to parathyroid dysfunction, hypocalcaemia, and hypokalaemia as a complication of long-term treatment with a proton pump inhibitor\u2014a literature review","volume":"75","author":"Bobrowicz","year":"2024","journal-title":"Endokrynol Pol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"luaf125","DOI":"10.1210\/jcemcr\/luaf125","article-title":"Late-onset complications in a chronic proton pump inhibitor user: electrolyte abnormalities and a diagnostic approach","volume":"3","author":"Tran","year":"2025","journal-title":"JCEM Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1752-1947-7-223","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"7","author":"Gagnier","year":"2013","journal-title":"J Med Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.0954-6820.1981.tb02648.x","article-title":"Magnesium deficiency. Etiology and clinical spectrum","volume":"209","author":"Flink","year":"1981","journal-title":"Acta Med Scand"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"617374","DOI":"10.3389\/fphys.2020.617374","article-title":"The ECG characteristics of patients with isolated hypomagnesemia","volume":"11","author":"Yang","year":"2021","journal-title":"Front Physiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2146\/ajhp110574","article-title":"Comparison of intravenous and oral magnesium replacement in hospitalized patients with cardiovascular disease","volume":"69","author":"Reed","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3923\/ijp.2017.603.611","article-title":"Role of Levetiracetam in the rehabilitation of dysphagia due to stroke","volume":"13","author":"Chen","year":"2017","journal-title":"Int J Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.09.005","article-title":"Efficacy and safety of Levetiracetam 1000\u20133000\u202fmg\/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study","volume":"63","author":"Beran","year":"2005","journal-title":"Epilepsy Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jocn.2011.09.032","article-title":"The acute effects of Levetiracetam on nocturnal sleep and daytime sleepiness in patients with partial epilepsy","volume":"19","author":"Zhou","year":"2012","journal-title":"J Clin Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11739-020-02501-1","article-title":"Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients","volume":"16","author":"Recart","year":"2021","journal-title":"Intern Emerg Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1517\/14740338.2013.809062","article-title":"Hypomagnesemia and proton-pump inhibitors","volume":"12","author":"Famularo","year":"2013","journal-title":"Expert Opin Drug Saf"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2036.2012.05201.x","article-title":"Systematic review: hypomagnesaemia induced by proton pump inhibition","volume":"36","author":"Hess","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","article-title":"A case series of proton pump inhibitor\u2013induced hypomagnesemia","volume":"56","author":"Hoorn","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"ref23","article-title":"Hypomagnesemia","volume-title":"StatPearls","author":"Gragossian","year":"2025"},{"key":"ref24","year":"2025"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"864514","DOI":"10.3389\/fnins.2022.864514","article-title":"Synaptic vesicle glycoprotein 2A: features and functions","volume":"16","author":"Rossi","year":"2022","journal-title":"Front Neurosci"},{"key":"ref26","article-title":"Physiology, NMDA receptor","volume-title":"StatPearls","author":"Jewett","year":"2025"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.4199\/C00027ED1V01Y201103ISP016","article-title":"Motor function of the pharynx, esophagus, and its sphincters","volume-title":"Integrated systems physiology: from molecule to function to disease","author":"Mittal","year":"2011"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000057395","article-title":"Hypomagnesemia and smooth muscle contractility: diffuse esophageal spasm in an old female patient","volume":"24","author":"Iannello","year":"1998","journal-title":"Miner Electrolyte Metab"},{"key":"ref29","first-page":"124","article-title":"Hypokalaemic paralysis revealing Sjogren\u2019s syndrome in a 16-year old girl","volume":"42","author":"Skalova","year":"2008","journal-title":"Ghana Med J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"omae174","DOI":"10.1093\/omcr\/omae174","article-title":"Parkinson\u2019s disease exacerbation following Levetiracetam administration: an unusual phenomenon","volume":"2025","author":"Alqahtani","year":"2025","journal-title":"Oxf Med Case Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"102732","DOI":"10.1016\/j.bas.2023.102732","article-title":"Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy","volume":"4","author":"Bianconi","year":"2024","journal-title":"Brain Spine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e42244","DOI":"10.1016\/j.heliyon.2025.e42244","article-title":"A meta-analytic evaluation of the efficacy and safety of levetiracetam for treating myoclonic seizures","volume":"11","author":"Najafi","year":"2025","journal-title":"Heliyon"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1646741\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:40:56Z","timestamp":1758087656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1646741\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":32,"alternative-id":["10.3389\/fmed.2025.1646741"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1646741","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"article-number":"1646741"}}